Article Details
Retrieved on: 2021-04-12 15:33:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The system is FDA approved to treat severe CSA in adult patients with reduced cardiac function. “Zoll and Respicardia both develop innovative therapies ...
Article found on: www.massdevice.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here